Scientists at the McGovern Institute and the Broad Institute of MIT and Harvard have reengineered a compact RNA-guided enzyme ...

Researchers using CRISPR-Cas9 gene editing tools have discovered that while this technology can enhance T cell cancer therapies, it may also lead to unintended chromosomal loss in the edited immune ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics ... are interrelated. Access to basic services is another ESG risk Crispr ...

we are excited to have these tools utilized by the community and also apply this framework to other properties and enzymes in the genome editing repertoire." CRISPR-Cas9 enzymes can be used to ...

While CRISPR ... gene editing has led to powerful advances across biology, medicine, and agriculture, challenges persist in optimizing the editing efficiency of enzymes, such as the widely used ...

Gene editing ... is relatively easy to diagnose at early stages of development. However, there are no treatments. Ryotaro ...

However, there are concerns that cutting the wrong gene or cutting too many times could cause genetic damage or new cancers. Peer and his team developed a CRISPR-Cas9 'delivery system' that uses ...

Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial. The Lancet ...

Collaborating with CRISPR-Cas9 co-inventor Jennifer Doudna and ... CRISPR system that uses the tobacco rattle virus to deliver gene-editing tools directly to the germ cells, or the reproductive ...